| Literature DB >> 32306978 |
Lulu Chen1, Mingzhen Yuan1, Lu Sun1, Yuelin Wang1, Youxin Chen2.
Abstract
BACKGROUND: To evaluate changes of microvascular network of macular and peripapillary regions and to provide a quantitative measurement of foveal avascular zone (FAZ) in unilateral BRVO patients.Entities:
Keywords: Branch retinal vein occlusion; Foveal avascular zone; Optical coherence tomography angiography; Radial peripapillary capillary; Retinal vasculature
Mesh:
Year: 2020 PMID: 32306978 PMCID: PMC7169004 DOI: 10.1186/s12886-020-01405-0
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Macular measurements in contralateral eyes and normal control eyes
| Variables | Contralateral unaffected eyes ( | Normal control eyes ( | |
|---|---|---|---|
| BCVA | 0.096 ± 0.143 | 0.040 ± 0.116 | 0.056 |
| Foveal retinal thickness(μm) | 248 ± 20 | 248 ± 19 | 0.954 |
| Vascular density in SVC (%) | |||
| Whole | 45.6 ± 3.5 | 47.2 ± 2.6 | 0.015 |
| Foveal | 15.5 ± 5.9 | 15.6 ± 6.6 | 0.963 |
| Temporal | 47.3 ± 3.5 | 48.8 ± 2.9 | 0.022 |
| Superior | 50.1 ± 3.9 | 51.5 ± 2.8 | 0.047 |
| Nasal | 47.5 ± 4.0 | 48.7 ± 5.3 | 0.204 |
| Inferior | 49.8 ± 4.0 | 51.1 ± 3.2 | 0.094 |
| Vascular density in DVC (%) | |||
| Whole | 50.0 ± 3.0 | 50.5 ± 3.3 | 0.451 |
| Foveal | 29.8 ± 8.0 | 28.7 ± 5.5 | 0.803 |
| Temporal | 52.7 ± 3.0 | 53.7 ± 3.2 | 0.141 |
| Superior | 52.0 ± 3.6 | 53.0 ± 3.2 | 0.142 |
| Nasal | 52.8 ± 3.2 | 53.9 ± 2.9 | 0.090 |
| Inferior | 52.2 ± 3.8 | 52.9 ± 3.9 | 0.340 |
| FAZ(mm2) | 0.325 ± 0.136 | 0.352 ± 0.090 | 0.270 |
| FAZ perimeter(mm) | 2.255 ± 0.503 | 2.345 ± 0.348 | 0.316 |
| AI | 1.14 ± 0.04 | 1.14 ± 0.04 | 0.686 |
| FD-300(%) | 49.21 ± 4.46 | 51.39 ± 3.56 | 0.010 |
Demographics and clinical characteristics of patients with BRVO
| Variables | Mean ± Standard Deviation |
|---|---|
| BRVO eyes | 47 |
| Age, y, mean ± SD | 55. 0 ± 11.0 (range, 25–82) |
| Sex, male/female | 22/25 |
| Affected eye, OD/OS | 30:17 |
| BCVA of BRVO eyes | 0.440 ± 0.324 |
| BCVA of fellow eyes | 0.096 ± 0.143 |
| Symptom duration of BRVO | 8.3 ± 14.7(range 0.5–46 months) |
| Superior/inferior, no | 39/8 |
Macular measurements in BRVO eyes and fellow eyes
| Variables | Eyes with BRVO ( | Contralateral unaffected eyes ( | |
|---|---|---|---|
| BCVA | 0.440 ± 0.324 | 0.096 ± 0.143 | < 0.001 |
| Foveal retinal thickness(μm) | 321 ± 113 | 248 ± 20 | < 0.001 |
| Vascular density in SVC (%) | |||
| Whole | 40.4 ± 4.0 | 45.6 ± 3.5 | < 0.001 |
| Foveal | 15.5 ± 5.0 | 15.5 ± 5.9 | 0.960 |
| Temporal | 41.3 ± 5.3 | 47.3 ± 3.5 | < 0.001 |
| Superior | 42.2 ± 7.5 | 50.1 ± 3.9 | < 0.001 |
| Nasal | 42.7 ± 6.0 | 47.5 ± 4.0 | < 0.001 |
| Inferior | 44.6 ± 5.5 | 49.8 ± 4.0 | < 0.001 |
| Vascular density in DVC (%) | |||
| Whole | 42.9 ± 5.0 | 50.0 ± 3.0 | < 0.001 |
| Foveal | 28.2 ± 9.3 | 29.8 ± 8.0 | 0.158 |
| Temporal | 44.0 ± 7.1 | 52.7 ± 3.0 | < 0.001 |
| Superior | 41.1 ± 8.8 | 52.0 ± 3.6 | < 0.001 |
| Nasal | 46.2 ± 6.4 | 52.8 ± 3.2 | < 0.001 |
| Inferior | 46.0 ± 7.4 | 52.2 ± 3.8 | < 0.001 |
| FAZ(mm2) | 0.394 ± 0.260 | 0.325 ± 0.136 | 0.046 |
| FAZ perimeter(mm) | 2.589 ± 1.108 | 2.255 ± 0.503 | 0.031 |
| AI | 1.23 ± 0.13 | 1.14 ± 0.04 | < 0.001 |
| FD-300(%) | 45.66 ± 6.04 | 49.21 ± 4.46 | < 0.001 |
Fig. 1Vessel density of SVC and DVC (a-b) in macular region of superior vein occlusion group and (c-d) inferior vein occlusion group. *, P < 0.05; SVC, superficial vascular complex; DVC, deep vascular complex
Peripapillary vessel density in BRVO eyes and fellow eyes
| Variables | Eyes with BRVO ( | Contralateral unaffected eyes ( | |
|---|---|---|---|
| Whole(%) | 44.7 ± 4.0 | 49.9 ± 2.3 | < 0.001 |
| Inside disc(%) | 46.8 ± 6.2 | 47.6 ± 5.4 | 0.390 |
| Peripapillary(%) | 47.8 ± 5.6 | 52.8 ± 3.1 | < 0.001 |
| Nasal superior(%) | 44.1 ± 5.6 | 48.9 ± 4.7 | 0.159 |
| Nasal inferior(%) | 47.2 ± 5.8 | 47.9 ± 4.8 | 0.410 |
| Inferior nasal(%) | 49.4 ± 9.1 | 52.5 ± 4.2 | 0.035 |
| Inferior temporal(%) | 52.9 ± 9.3 | 58.4 ± 4.5 | < 0.001 |
| Temporal inferior(%) | 52.4 ± 6.4 | 53.3 ± 5.0 | 0.337 |
| Temporal superior(%) | 54.4 ± 4.2 | 56.7 ± 3.7 | 0.005 |
| Superior temporal(%) | 49.0 ± 7.9 | 56.6 ± 4.1 | < 0.001 |
| Superior nasal(%) | 47.4 ± 7.4 | 51.3 ± 4.5 | < 0.001 |
Peripapillary vessel density in contralateral unaffected eyes and normal control eyes
| Variables | Contralateral unaffected eyes ( | Normal control eyes ( | |
|---|---|---|---|
| Whole(%) | 49.9 ± 2.3 | 50.7 ± 1.6 | 0.040 |
| Inside disc(%) | 47.6 ± 5.4 | 50.7 ± 5.3 | 0.007 |
| Peripapillary(%) | 52.8 ± 3.1 | 53.2 ± 2.2 | 0.467 |
| Nasal superior(%) | 48.9 ± 4.7 | 49.1 ± 4.0 | 0.798 |
| Nasal inferior(%) | 47.9 ± 4.8 | 48.7 ± 4.1 | 0.394 |
| Inferior nasal(%) | 52.5 ± 4.2 | 53.0 ± 3.6 | 0.588 |
| Inferior temporal(%) | 58.4 ± 4.5 | 58.4 ± 3.5 | 0.953 |
| Temporal inferior(%) | 53.3 ± 5.0 | 53.7 ± 3.3 | 0.642 |
| Temporal superior(%) | 56.7 ± 3.7 | 57.6 ± 2.6 | 0.174 |
| Superior temporal(%) | 56.6 ± 4.1 | 56.9 ± 3.1 | 0.719 |
| Superior nasal(%) | 51.3 ± 4.5 | 51.2 ± 4.2 | 0.855 |
Fig. 2Vessel density of RPC in a superior vein occlusion group and b inferior vein occlusion group. RPC, radial peripapillary capillary; s-hemi, superior -hemi; i-hemi, inferior-hemi TS, temporal superior; ST, superior temporal; SN, superior nasal; IT, inferior temporal; TI, temporal inferior; IN, inferior nasal; *, P < 0.05